GLP-3 Receptor Agonists (GLP-3R)

The GLP-3 receptor (Glucagon-like peptide-3) is a key regulatory target in gastrointestinal physiology and metabolic research. This receptor plays a critical role in the modulation of intestinal motility, nutrient absorption, and satiety responses. Research-use-only peptide agents targeting the GLP-3 receptor are being investigated in preclinical studies for their potential effects on gastrointestinal function, including modulation of gut motility, regulation of intestinal hormone secretion, and potential therapeutic implications in gastrointestinal disorders.

Research Context

GLP-3 is a 30-amino acid peptide hormone released primarily from L-cells in the distal intestine in response to postprandial nutrient exposure. Its primary function is to inhibit gastric emptying and stimulate intestinal motility, contributing to the regulation of meal processing and satiety. Peptide agonists that selectively target the GLP-3 receptor represent a promising area of investigation for understanding gastrointestinal physiology and developing novel therapeutic approaches.

Research Overview

GLP-3 receptor agonism has been extensively studied in preclinical models as a means to explore the functional and mechanistic roles of this receptor in gastrointestinal physiology. These investigations include studies on the effects of GLP-3 peptides on:

• Gastrointestinal motility and peristaltic activity
• Regulation of intestinal hormone secretion
• Modulation of nutrient absorption
• Potential implications in gastrointestinal disorders, such as gastroparesis or chronic diarrhea

The data generated from these studies are critical for advancing our understanding of GLP-3-mediated signaling pathways and for guiding the development of future research tools or therapeutic agents.

Key Research Focus Areas

• • Basic Mechanistic Studies:

Exploration of the molecular and cellular mechanisms by which GLP-3 receptor agonists modulate gastrointestinal function, including signal transduction pathways, receptor desensitization, and adaptive responses.

• • Pharmacological Profiling:

Characterization of peptide potency, duration of action, and specificity for GLP-3 receptors compared to related receptors, such as GLP-1 or GLP-2, to identify optimal research tools for targeted investigations.

• • Preclinical Models:

Evaluation of peptide effects in animal models of gastrointestinal disorders, such as delayed gastric emptying, intestinal dysmotility, or inflammatory bowel conditions, to assess potential therapeutic efficacy and safety profiles.

• • Metabolic and Endocrine Studies:

Investigation of the broader metabolic effects of GLP-3 receptor agonism, including interactions with other hormonal pathways and potential consequences for energy balance and nutrient homeostasis.

This peptide is intended for use solely in academic and industrial research settings to support scientific investigations. It is not intended for human or animal therapeutic use.

For research use only. Not for human or animal consumption.

Storage and handling instructions should be followed according to the manufacturer’s guidelines for maintaining stability and activity.